{"database":"GNPS","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://massive-ftp.ucsd.edu/v02/MSV000082714/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Metabolomics"],"submitter":["Maureen Kachman"],"instrument_platform":["QTOF - NEGATIVE","QTOF - POSITIVE"],"species":["Homo Sapiens"],"full_dataset_link":["https://massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=4773717a2b1e49819eda9bf37b17393c"],"submitter_email":["mkachman@med.umich.edu"],"submitter_affiliation":["University of Michigan"],"sample_protocol":[""],"repository":["GNPS"],"file_size":["259"],"ptm_modification":["MS:1002864 - No post-translational-modifications are included in the identified peptides of this dataset"],"data_protocol":[""],"additional_accession":[]},"is_claimable":false,"name":"Metabolomics Workbench ST000677 - GNPS - Nonalcoholic steatohepatitis (NASH) changes with S.Q. Leptin administrations","description":"Samples are from individuals with documented fatty liver disease (NAFLD) from whom serum was drawn at baseline and after 1 and 12 months of S.Q. Leptin administrations. The effect of leptin on degree of steatosis and inflammation was assessed in liver biopsies at baseline and following 1 year of treatment.","dates":{"publication":"Thu Aug 02 17:17:00 BST 2018"},"accession":"MSV000082714","cross_references":{"TAXONOMY":["9606"]}}